The Vanderbilt Specialty Pharmacy Health Outcomes and Research Program was established to improve patient care through sound research while furthering innovation and insights within the field of specialty pharmacy.


We focus on the link between specialty pharmacy medications, health care delivery and patient outcomes by performing research that encompasses the complete patient journey, from evaluation through treatment. Specifically, we are committed to:
parallax background


We are uniquely positioned to produce rigorous, innovative, meaningful outcomes research. Our outcomes program leverages the expertise and experience of world-renowned physician champions within the Vanderbilt University Medical Center. We also fuel our efforts through a partnership with the Department of Biostatistics, a collaborative population health department and a cutting edge Health IT department to ensure our projects are solid and sound.




  • Association of Managed Care and Specialty Pharmacy Annual Meeting
    • Gold ribbon abstract winners
      • A Targeted Approach to Reducing Rates of Discontinuation and Dose Reduction in Patients Receiving Sorafenib or Regorafenib
      • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic


  • American College of Gastroenterology Meeting
    • Recognized as Best of ACG 2018 IBD & Liver
      • Risk Factors for Non-Adherence to Biologic Therapy in Adult Patients with Inflammatory Bowel Disease (IBD): A Retrospective Analysis
  • Academy of Managed Care and Specialty Pharmacy Nexus Meeting
    • Silver Ribbon Abstract
      • Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population


  • National Association of Specialty Pharmacy Annual Meeting
    • Third place abstract winner
      • Assessing the Impact of High Touch Specialty Pharmacy Services in Patients Receiving Teriparatide